Skip to content
IP + Technology Law
Home  »  News & Insights  »  News  »  Media Mention

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

Blogs
Aug 2026
U.S. Patent Claim Strategies for In-Space Repair and Orbital Assembly Technologies
Key Takeaways: Given the territorial limitations of U.S. Patent Claims, patenting technology for in-space repair and assembly of orbital technology can be challenging. The following blog post discusses strategies for...
Newsletters
Aug 2026
Federal Circuit Review | July 2026
PTAB May Revisit Issues Left Unresolved by Prior Appeal In Intellectual Pixels Limited v. Sony Interactive Entertainment LLC, Appeal No. 24-2174, The Board did not exceed the Federal Circuit’s mandate...
Newsletters
Aug 2026
Energy Update | July 2026
Solar Boom Highlights Importance of Robust IP Strategy Michael E. Salamy Solar has reached a historic milestone, surpassing coal in U.S. electricity generation as rising demand and record investment accelerate...